Home > Press > HydroGen Corporation Reports Results for the Fiscal 2007 Third Quarter
Abstract:
HydroGen Corporation (Nasdaq:HYDG), a designer and manufacturer of multi-megawatt air-cooled phosphoric acid fuel cell (PAFC) systems, today announced its financial results for the quarter ended September 30, 2007. HydroGen is currently in the development stage and is expected to remain so for at least the next several quarters.
Recent Operational Highlights
* HydroGen Corporation announced that the Pennsylvania Energy
Development Authority (PEDA) granted the Company $500,000 to fund
the design, manufacture, and installation of commercial scale gas
clean-up modules to validate the use of surplus hydrogen-rich coke
oven gas for commercial scale fuel cell power plants to produce
electricity. HydroGen will be working in cooperation with U.S.
Steel's Mon Valley Works plant in Mon Valley, PA.
* The Company also announced that the Pennsylvania NanoMaterials
Commercialization Center awarded the Company approximately $230,000
to support the development of advanced fuel cell catalyst systems.
HydroGen will be working in cooperation with the University of
Pittsburgh's Peterson Institute of Nano Science and Engineering on
this project. This award complements HydroGen's ongoing efforts to
develop state-of-the-art catalysts as recent developments in
nanomaterials have the potential to yield commercially available
fuel cell catalysts that will lead to longer lifetimes and lower
life-cycle costs.
* HydroGen also noted the continued progress for the production and
delivery of a PAFC module to the Company's 400 kW commercial
demonstration power plant at a chlor-alkali manufacturing plant
owned and operated by ASHTA Chemicals, Inc.
"We have made steady progress in our mission to achieve commercialization," said Dr. Leo Blomen, Chairman and Chief Executive Officer of HydroGen Corporation. "We are working hard to prepare to deliver and validate our core PAFC module at our 400 kW commercial demonstration plant, and anticipate commercial activity in line with our business objectives to follow on the heels of successful demonstration at ASHTA. We have developed a large pipeline of projects with several large generators of by-product hydrogen and other potential customers in North America and abroad who have expressed interest in acquiring fuel cell power plants. We anticipate that as we transition into 2008, the Company will accelerate quickly into commercialization of our technology, with expanded manufacturing activities as well as plant design, engineering, and construction."
Joshua Tosteson, President of HydroGen Corporation, added: "With energy prices reaching new highs and concerns related to climate change in the forefront, interest in our technology among industrial companies continues to grow. These companies are drawn to the compelling economic proposition offered by our technology as they seek viable, environmentally-safe solutions for on-site distributed electric power generation. In addition, the use of clean technology continues to gain traction as a result of government incentives and increasingly stringent environmental standards. HydroGen is in a position to fully capitalize on these trends as we will continue to execute our strategic plan which will lead to commercialization in the coming year."
2007 Third Quarter Results
For the quarter ended September 30, 2007, HydroGen's net loss was $3.5 million, or $(0.27) per basic and diluted share, based on the weighted average of 12,769,904 common shares outstanding. This compares with a net loss of $2.2 million, or $(0.17) per basic and diluted share for the quarter ended September 30, 2006, based on the weighted average of 12,769,904 common shares outstanding.
HydroGen's balance of cash, cash equivalents and short-term investments at September 30, 2007, totaled $12.2 million as compared to a balance totaling $24.1 million at December 31, 2006. Spending on research and development for fiscal 2007 third quarter amounted to $2.5 million, increasing more than 37% over the third quarter of 2006.
####
About HydroGen Corporation
HydroGen Corporation is a manufacturer of multi-megawatt fuel cell systems utilizing its proprietary 400 kW phosphoric acid fuel cell (PAFC) technology. HydroGen's fuel cell technology, originally developed by Westinghouse Corporation, offers a multi-megawatt, zero-emission power generation product that supports the growth of industrial distributed energy. The Company targets market applications where hydrogen is currently available and other drivers favoring the adoption of fuel cells are present.
Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding HydroGen's anticipated economically competitive fuel cell systems. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as fluctuations in demand for HydroGen's products, HydroGen's ability to maintain strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of HydroGen's liquidity and financial strength to support its growth, and other information that may be detailed from time to time in HydroGen's filings with the United States Securities and Exchange Commission. HydroGen undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
HYDROGEN CORPORATION AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, DECEMBER 31, 2007 2006 ------------- ------------- (unaudited) ASSETS ------ CURRENT ASSETS -------------- Cash and cash equivalents $ 12,152,784 $ 14,170,530 Short-term investments -- 9,889,603 Accounts receivable 511,884 262,408 Other current assets 1,499,934 1,289,995 ------------- ------------- TOTAL CURRENT ASSETS 14,164,602 25,612,536 Property and equipment, net 4,488,125 3,469,533 Other assets 66,433 57,017 ------------- ------------- TOTAL ASSETS $ 18,719,160 $ 29,139,086 ============= ============= LIABILITIES AND SHAREHOLDERS' EQUITY ------------------------------------ CURRENT LIABILITIES ------------------- Accounts payable and accrued expenses $ 1,632,569 $ 1,659,441 Capital lease obligations, current portion 100,581 72,295 ------------- ------------- TOTAL CURRENT LIABILITIES 1,733,150 1,731,736 LONG-TERM LIABILITIES --------------------- Capital lease obligations, net of current portion 101,217 119,773 ------------- ------------- TOTAL LIABILITIES $ 1,834,367 $ 1,851,509 ============= ============= Common stock, $0.001 per share par value, authorized 65,000,000 shares, 12,769,904 issued and outstanding at September 30, 2007 and December 31, 2006 12,770 12,770 Additional paid-in capital 42,913,469 42,595,815 Deficit accumulated during the development stage (26,041,446) (15,321,008) ------------- ------------- TOTAL SHAREHOLDERS' EQUITY 16,884,793 27,287,577 ------------- ------------- TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 18,719,160 $ 29,139,086 ============= ============= HYDROGEN CORPORATION AND SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS NOVEMBER 11, FOR THE THREE FOR THE NINE 2001 MONTHS ENDED MONTHS ENDED (INCEPTION) SEPTEMBER 30, SEPTEMBER 30, THROUGH --------------------- ---------------------- SEPTEMBER 30, 2007 2006 2007 2006 2007 ---------- ---------- ----------- ---------- ----------- Demonstration Grant Revenue $ 481,884 $ 219,847 $ 1,298,568 $ 348,301 $ 2,045,991 ---------- ---------- ----------- ---------- ----------- Costs and expenses (including stock-based compensation expense of $41,922 and $63,461, for the three month periods ended September 30, 2007 and September 30, 2006, respectively, and $317,654 and $259,744 for the nine month periods ended September 30, 2007 and September 30, 2006, respec- tively.) 4,115,792 2,745,432 12,671,154 5,951,876 28,189,308 ---------- ---------- ----------- ---------- ----------- LOSS FROM OPERATIONS (3,633,908)(2,525,585)(11,372,586)(5,603,575)(26,143,317) ---------- ---------- ----------- ---------- ----------- Interest and other income 164,102 352,344 667,150 713,094 1,911,169 Interest and other financing charges (5,676) (5,698) (15,002) (90,456) (785,487) Charge for repricing conversion price of convertible debt -- -- -- -- (875,000) ---------- ---------- ----------- ---------- ----------- NET LOSS (3,475,482)(2,178,939)(10,720,438)(4,980,937)(25,892,635) ========== ========== =========== ========== =========== Weighted average common shares outstanding (basic and diluted) 12,769,904 12,769,904 12,769,904 10,485,087 ---------- ---------- ----------- ---------- Net loss per share (basic and diluted) (0.27) (0.17) (0.83) (0.48) ---------- ---------- ----------- ----------
For more information, please click here
Contacts:
HydroGen Corporation
Scott Schecter, Chief Financial Officer
(212) 672-0380 x 3002
Makovsky + Company
Investor Relations
Hulus Alpay
(212) 508-9600
Copyright © PrimeNewswire, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||